CURRENT
ISSUE
1728

The FDA has approved Cologuard Plus (Exact Sciences), a new at-home multitarget stool DNA test, for colorectal cancer (CRC) screening in average-risk adults ≥45 years old. Cologuard, the first FDA-approved multitarget stool DNA test, has been available since 2014.1

COLORECTAL CANCER SCREENING — Guidelines recommend screening average-risk adults for CRC beginning at age 45. Colonoscopy is generally the preferred method of screening; it can detect precancerous adenomas and allows for biopsy and removal of lesions during the procedure. Fecal immunochemical...  Continue reading

Coming Soon
Drugs for Chronic Heart Failure
Shield – A Blood Test for Colorectal Cancer
Guselkumab (Tremfya) for Crohn's Disease